Literature DB >> 32184359

Glucose availability but not changes in pancreatic hormones sensitizes hepatic AMPK activity during nutritional transition in rodents.

Camille Huet1, Nadia Boudaba1, Bruno Guigas2, Benoit Viollet1, Marc Foretz3.   

Abstract

The cellular energy sensor AMP-activated protein kinase (AMPK) is a metabolic regulator that mediates adaptation to nutritional variations to maintain a proper energy balance in cells. We show here that suckling-weaning and fasting-refeeding transitions in rodents are associated with changes in AMPK activation and the cellular energy state in the liver. These nutritional transitions were characterized by a metabolic switch from lipid to glucose utilization, orchestrated by modifications in glucose levels and the glucagon/insulin ratio in the bloodstream. We therefore investigated the respective roles of glucose and pancreatic hormones on AMPK activation in mouse primary hepatocytes. We found that glucose starvation transiently activates AMPK, whereas changes in glucagon and insulin levels had no impact on AMPK. Challenge of hepatocytes with metformin-induced metabolic stress strengthened both AMPK activation and cellular energy depletion under limited-glucose conditions, whereas neither glucagon nor insulin altered AMPK activation. Although both insulin and glucagon induced AMPKα phosphorylation at its Ser485/491 residue, they did not affect its activity. Finally, the decrease in cellular ATP levels in response to an energy stress was additionally exacerbated under fasting conditions and by AMPK deficiency in hepatocytes, revealing metabolic inflexibility and emphasizing the importance of AMPK for maintaining hepatic energy charge. Our results suggest that nutritional changes (i.e. glucose availability), rather than the related hormonal changes (i.e. the glucagon/insulin ratio), sensitize AMPK activation to the energetic stress induced by the dietary transition during fasting. This effect is critical for preserving the cellular energy state in the liver.
© 2020 Huet et al.

Entities:  

Keywords:  AMP-activated kinase (AMPK); energy homeostasis; glucagon; glucose; hepatocyte; insulin; liver; metabolic regulation; metformin; nutrient sensing; nutritional transition

Mesh:

Substances:

Year:  2020        PMID: 32184359      PMCID: PMC7196663          DOI: 10.1074/jbc.RA119.010244

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase.

Authors:  Jamel Mankouri; Philip R Tedbury; Sarah Gretton; Mair E Hughes; Stephen D C Griffin; Mark L Dallas; Kevin A Green; D Grahame Hardie; Chris Peers; Mark Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

Authors:  Marc Foretz; Sophie Hébrard; Jocelyne Leclerc; Elham Zarrinpashneh; Maud Soty; Gilles Mithieux; Kei Sakamoto; Fabrizio Andreelli; Benoit Viollet
Journal:  J Clin Invest       Date:  2010-06-23       Impact factor: 14.808

3.  AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.

Authors:  Murwarid M Assifi; Gabriela Suchankova; Scarlet Constant; Marc Prentki; Asish K Saha; Neil B Ruderman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-14       Impact factor: 4.310

4.  Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes.

Authors:  Maria W Sun; Jennifer Y Lee; Paul I W de Bakker; Noël P Burtt; Peter Almgren; Lennart Råstam; Tiinamaija Tuomi; Daniel Gaudet; Mark J Daly; Joel N Hirschhorn; David Altshuler; Leif Groop; Jose C Florez
Journal:  Diabetes       Date:  2006-03       Impact factor: 9.461

5.  Adenosine triphosphate conservation in metabolic regulation. Rat liver citrate cleavage enzyme.

Authors:  D E Atkinson; G M Walton
Journal:  J Biol Chem       Date:  1967-07-10       Impact factor: 5.157

6.  Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans.

Authors:  Marie-Soleil Gauthier; Elena L O'Brien; Sherman Bigornia; Melanie Mott; Jose M Cacicedo; X Julia Xu; Noyan Gokce; Caroline Apovian; Neil Ruderman
Journal:  Biochem Biophys Res Commun       Date:  2010-12-03       Impact factor: 3.575

7.  Role of AMP-activated protein kinase and adiponectin during development of hepatic steatosis in high-fat diet-induced obesity in rats.

Authors:  S-K Ha; J Kim; C Chae
Journal:  J Comp Pathol       Date:  2011-01-20       Impact factor: 1.311

8.  Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress.

Authors:  Erin Quan Toyama; Sébastien Herzig; Julien Courchet; Tommy L Lewis; Oliver C Losón; Kristina Hellberg; Nathan P Young; Hsiuchen Chen; Franck Polleux; David C Chan; Reuben J Shaw
Journal:  Science       Date:  2016-01-15       Impact factor: 47.728

9.  Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

Authors:  Sandrine Horman; Didier Vertommen; Richard Heath; Dietbert Neumann; Véronique Mouton; Angela Woods; Uwe Schlattner; Theo Wallimann; David Carling; Louis Hue; Mark H Rider
Journal:  J Biol Chem       Date:  2005-12-09       Impact factor: 5.157

10.  Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin.

Authors:  Morgan D Fullerton; Sandra Galic; Katarina Marcinko; Sarah Sikkema; Thomas Pulinilkunnil; Zhi-Ping Chen; Hayley M O'Neill; Rebecca J Ford; Rengasamy Palanivel; Matthew O'Brien; D Grahame Hardie; S Lance Macaulay; Jonathan D Schertzer; Jason R B Dyck; Bryce J van Denderen; Bruce E Kemp; Gregory R Steinberg
Journal:  Nat Med       Date:  2013-11-03       Impact factor: 53.440

View more
  4 in total

1.  AMPK Modulates the Metabolic Adaptation of C6 Glioma Cells in Glucose-Deprived Conditions without Affecting Glutamate Transport.

Authors:  Inês Belo do Nascimento; Marie Verfaillie; Gamze Ates; Pauline Beckers; Virginie Joris; Nathalie Desmet; Ann Massie; Emmanuel Hermans
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

Review 2.  The Protective Role of the Carbohydrate Response Element Binding Protein in the Liver: The Metabolite Perspective.

Authors:  Loranne Agius; Shruti S Chachra; Brian E Ford
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-17       Impact factor: 5.555

3.  The Marine-Derived Macrolactone Mandelalide A Is an Indirect Activator of AMPK.

Authors:  Daphne R Mattos; Xuemei Wan; Jeffrey D Serrill; Minh H Nguyen; Ian R Humphreys; Benoit Viollet; Amos B Smith; Kerry L McPhail; Jane E Ishmael
Journal:  Mar Drugs       Date:  2022-06-27       Impact factor: 6.085

Review 4.  The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective.

Authors:  Loranne Agius; Brian E Ford; Shruti S Chachra
Journal:  Int J Mol Sci       Date:  2020-05-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.